journal article·2017-04

Peptide nanoparticle with pH-sensing cargo solubility enhances cancer drug efficiency

Hoon Choi, Ting Liu, Kavindra Nath, Rong Zhou, I-Wei Chen

Nano Today· Volume 13
Publisher page

Abstract

Abstract We report a class of 17-amino-acid peptides that undergo a sharp hydrophobicity transition at pH around 7. Nanoparticles made of such peptides exhibit ultra pH-sensitivity and autonomous drug-eluting properties, which are beneficial for cancer drug delivery. At pH above 7, the peptides bind water-insoluble drug cargo and form a nanoparticle that protects its cargo from serum proteins. Sensing tumor's mildly acidic pH (≤7.0), nanoparticle peptides undergo a hydrophobic-to-hydrophilic transition and release drug molecules in the interstitial fluid as the nanoparticle migrates down the pH gradient in the tumor. When this pH-sensing and drug-eluting nanoparticle formulation was used to deliver two drugs, lonidamine inhibiting tumor bioenergetics and bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) targeting cancer glutamine metabolism, to triple negative human breast cancer xenografts, the nanoparticle drug demonstrated superior efficiency compared to the respective standard formulation.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Mass Spectrometry Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Nichols · Nano Today · 2012 · 7 · 60610.1016/j.nantod.2012.10.010 ↗
2. Barua · Nano Today · 2014 · 9 · 22310.1016/j.nantod.2014.04.008 ↗
3. Liu · Biotechnol. Adv. · 2014 · 32 · 69310.1016/j.biotechadv.2013.11.009 ↗
4. Li · Adv. Drug Deliv. Rev. · 2004 · 56 · 96710.1016/j.addr.2003.10.041 ↗
5. An · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 2024610.1073/pnas.1014403107 ↗
6. Andreev · Mol. Membr. Biol. · 2010 · 27 · 34110.3109/09687688.2010.509285 ↗
7. Gerweck · Cancer Res. · 1996 · 56 · 1194
8. Kato · Cancer Cell Int. · 2013 · 13 · 8910.1186/1475-2867-13-89 ↗
9. Stubbs · Mol. Med. Today · 2000 · 6 · 1510.1016/S1357-4310(99)01615-9 ↗
10. Estrella · Cancer Res. · 2013 · 73 · 152410.1158/0008-5472.CAN-12-2796 ↗
11. Gatenby · Cancer Res. · 2006 · 66 · 521610.1158/0008-5472.CAN-05-4193 ↗
12. Lee · J. Control. Rel. · 2003 · 91 · 10310.1016/S0168-3659(03)00239-6 ↗
13. Lee · J. Control. Rel. · 2007 · 123 · 1910.1016/j.jconrel.2007.08.006 ↗
14. Huh · Macromol. Res. · 2012 · 20 · 22410.1007/s13233-012-0059-5 ↗
15. Lee · Nano Lett. · 2005 · 5 · 32510.1021/nl0479987 ↗
16. Wang · Nat. Mater. · 2014 · 13 · 20410.1038/nmat3819 ↗
17. Ben-Yoseph · J. Neurooncol. · 1998 · 36 · 14910.1023/A:1005819604858 ↗
18. Nath · NMR Biomed. · 2015 · 28 · 28110.1002/nbm.3240 ↗
19. Nath · NMR Biomed. · 2013 · 26 · 9810.1002/nbm.2824 ↗
20. Fang · Mol. Pharmacol. · 2006 · 70 · 210810.1124/mol.106.026245 ↗
21. Ben-Horin · Cancer Res. · 1995 · 55 · 2814
22. Floridi · Cancer Res. · 1981 · 41 · 4661
23. Nancolas · Biochem. J · 2016 · 473 · 92910.1042/BJ20151120 ↗
24. Thangavelu · Proc. Natl. Acad. Sci. U. S. A. · 2012 · 109 · 770510.1073/pnas.1116573109 ↗
25. Le · Cell Metab. · 2012 · 15 · 11010.1016/j.cmet.2011.12.009 ↗
26. DeBerardinis · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 1934510.1073/pnas.0709747104 ↗
27. Di Cosimo · Drugs Today · 2003 · 39 · 15710.1358/dot.2003.39.3.799451 ↗
28. Price · Cancer Chemother. Pharmacol. · 1996 · 38 · 12910.1007/s002800050460 ↗
29. Zhou · Cancer Res. · 2000 · 60 · 3532
30. Madden · NMR Biomed. · 1991 · 4 · 110.1002/nbm.1940040102 ↗
31. I-W. Chen, H. Choi, R. Zhou, US Patent Application 20160213790 (2016).
32. Werle · Amino Acids · 2006 · 30 · 35110.1007/s00726-005-0289-3 ↗
33. Halestrap · Biochem. J · 1999 · 343 · 28110.1042/bj3430281 ↗
34. Wang · Mol. Pharm. · 2006 · 3 · 67510.1021/mp060037b ↗
35. Adkins · Mol. Cell. Proteomics · 2002 · 1 · 94710.1074/mcp.M200066-MCP200 ↗
36. Choi · Clin. Chim. Acta · 2004 · 339 · 14710.1016/j.cccn.2003.10.002 ↗
37. Wiig · J. Physiol. · 2005 · 567 · 55710.1113/jphysiol.2005.089615 ↗
38. Wiig · Am. J. Physiol. Heart Circ. Physiol. · 2003 · 284 · H41610.1152/ajpheart.00327.2002 ↗
39. Gullino · Cancer Res. · 1964 · 24 · 780
40. Jain · Cancer Res. · 1987 · 47 · 3039
41. Tong · Cancer Res. · 2004 · 64 · 373110.1158/0008-5472.CAN-04-0074 ↗
42. Philip Nelson · 2014
43. Smith · Nat. Rev. Drug Discov. · 2010 · 9 · 92910.1038/nrd3287 ↗
44. Koch-Weser · N. Engl. J. Med. · 1976 · 294 · 31110.1056/NEJM197602052940605 ↗
45. Koch-Weser · N. Engl. J. Med. · 1976 · 294 · 52610.1056/NEJM197603042941005 ↗
46. Maeda · J. Control. Rel. · 2000 · 65 · 27110.1016/S0168-3659(99)00248-5 ↗
47. Goel · Physiol. Rev. · 2011 · 91 · 107110.1152/physrev.00038.2010 ↗
48. Trédan · J. Natl. Cancer Inst. · 2007 · 99 · 144110.1093/jnci/djm135 ↗